Skip to main content

Day: April 16, 2024

ORAPI : CHIFFRE D’AFFAIRES T1 2024 – Recul des ventes de 2,1% à périmètre comparable

Communiqué de presse         Lyon – Saint-Vulbas, le 16 avril 2024 à 18h CHIFFRE D’AFFAIRES DU T1 2024 Recul des ventes : -2,1% à PC*En M€ T1 2023 T1 2024Europe 57,4 56,4Amérique du Nord 0,5 0,5Asie et reste du Monde 2,8 2,5Total Périmètre Comparable* 60,7 59,4Total périmètre courant 61,2 59,4*à PC (à périmètre comparable) ORAPI enregistre sur le premier trimestre 2024, un chiffre d’affaires de 59,4 M€ contre 60,7 M€ au T1 2023. Dans un contexte déflationniste, le niveau d’activité connaît un repli de -2,1% à PC*. A périmètre courant, le repli de -2,9% intègre comme prévu l’arrêt des activités de la filiale scandinave. En France, principal marché du Groupe, le chiffre d’affaires s’établit à 51,5 M€ en repli de -1,6% (-0,8 M€) vs un T1 2023 encore impacté par un fort effet « inflation ». Au-delà de l’effet de la déflation...

Continue reading

Tonner Drones Announces Strategic Repositioning

Tonner Drones Announces Strategic Repositioning Cannes, 16 april 2024 18:00Successful finalization of the capital increase ended the refinancing period 12 months financial visibility Stable financial situation enables the company to intensify talks with partners for collaboration TonnerDrones notices a lot of interest in collaboration under its stock exchange listing TonnerDrones recently ended Equity-line product with Yorkville and has no interest in entering into new variable price financing Tonner Drones will continue to update the market about its new future.Tonner Drones’ successful capital increase ends a challenging financial restructuring period for the company that included cost cutting measures and addressing numerous legacy issues that management inherited upon their arrival in June of 2023. Tonner’s refocused strategy...

Continue reading

Haffner Energy: a broader positioning and a new website to better serve our addressable market in Europe and the rest of the world

Haffner Energy: a broader positioning and a new website to better serve our addressable market in Europe and the rest of the world Vitry-le-François, France, April 16, 2024, at 6.00 pm (CEST) Stemming from a single technology, Haffner Energy’s offering has grown steadily over the years to meet market needs and address decarbonization challenges. The company’s addressable market includes players in industry, land, air and marine mobility, as well as governments and local authorities. Haffner Energy’s offer also contributes to regenerating the planet through the co-production of biogenic CO2 and/or biochar, a natural and sustainable carbon sink. The renewable energy production solutions we offer, based on our thermolysis technology, are designed for a wide range of uses. We can serve customers who need renewable gas and hydrogen,...

Continue reading

OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective

OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective NANTES, France, April 16, 2024 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage immunotherapy company, today announced that the Hart-Scott-Rodino waiting period has expired with respect to its global license with AbbVie to develop OSE-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently in the pre-clinical development stage. As part of the partnership agreement announced on February 28, 2024, AbbVie received from OSE Immunotherapeutics an exclusive global license and collaboration agreement to develop OSE-230, a monoclonal antibody designed to resolve chronic inflammation. Under the terms of this agreement, AbbVie will now make an upfront...

Continue reading

First half business review

First half business review On November 10, 2023, Derichebourg Group suffered a cyberattack that did not interrupt operations but disrupted progress. Our teams’ admirable responsiveness allowed us to restore our systems, improving them at the same time, and limit the consequences of this episode, which is luckily now behind us. However, this cyberattack disrupted business operations due to the temporary unavailability of the main operating software, particularly in November and December 2023 and, to a lesser extent, January 2024.  As such, the lack of an appropriate operating management tool led to purchasing volume losses and delayed computer entry of flows. Furthermore, once the administrative delay was caught up, the margins generated in November and December 2023 were lower than usual. As a result, the financial impact of the cyberattack...

Continue reading

VINCI Airports – Traffic at 31 March 2024

  Nanterre, 16 April 2024 VINCI Airports – Traffic at 31 March 2024Traffic rose 12% in Q1 2024 compared with Q1 2023 VINCI Airports’ overall traffic slightly outpaces 2019 levels, for the second consecutive quarter, buoyed by the strong results achieved in Portugal, Serbia, the Dominican Republic and Costa Rica Traffic growth continues in the remaining recovering markets in the United Kingdom, Chile, Japan and FranceIn the following paragraphs, all comparisons are relative to Q1 2023 unless otherwise indicated. Over 62 million passengers travelled through airports in the VINCI Airports network in Q1 2024 – 12% more than in Q1 2023 (and 0.6% higher than in Q1 2019). Traffic continued to hit record highs in certain locations, driven by strong demand and the opening of new markets. Growth remained robust in the Dominican Republic, reflecting...

Continue reading

Caldwell U.S. Dividend Advantage Fund Declares Distributions for Q2 2024

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 16, 2024 (GLOBE NEWSWIRE) — Caldwell Investment Management Ltd., the manager of Caldwell U.S. Dividend Advantage Fund (the “Fund”), is pleased to announce the payment of distributions on the actively-managed ETF Series of the Fund to unitholders of record as indicated below. The monthly distribution rate of CAD $0.038 per unit of the ETF Series represents an attractive annualized yield on net assets of approximately 2.8 %.Record Date Payment Date Distribution per UnitApril 29, 2024 May 6, 2024 CAD $0.038May 30, 2024 June 6, 2024 CAD $0.038June 27, 2024 July 5, 2024 CAD $0.038ETF Series unitholders also have the option to participate in the distribution reinvestment plan (“DRIP”) offered by the Fund, which...

Continue reading

Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) (“PBM” or “Psyence Biomed“), has announced that its Australian subsidiary, Psyence Australia Pty Ltd (“Psyence Australia“), has entered into a partnership with Fluence, a global leader in professional education and training for psychedelic therapy research, and iNGENū CRO Pty Ltd (“iNGENū“), an Australian clinical research organization (CRO), to support an upcoming Phase llb clinical trial. According to a news release issued by PBM on April 8, 2024, Fluence’s highly credentialed...

Continue reading

Synaptics to Report Third Quarter Fiscal 2024 Results on May 9, 2024

SAN JOSE, Calif., April 16, 2024 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced that it will report financial results for the third quarter of fiscal 2024 on Thursday, May 9, 2024 after the close of market. The Company will host a corresponding conference call for analysts and investors at 2:00 p.m. PT (5:00 p.m. ET), during which management may discuss forward-looking information. To participate on the live call, analysts and investors should pre-register at Synaptics Q3 FY2024 Earnings Call Registration. https://register.vevent.com/register/BI72ab1ea3c0414c749d5da3169a082980 Registrants will receive dial-in information and a unique passcode to access the call. We encourage participants to dial-in into the call ten minutes ahead of scheduled time. Synaptics will also offer a live and archived webcast...

Continue reading

Notification of a shareholder’s intention to submit a mandatory non-competitive takeover bid the remaining shares of AB Snaigė

Snaigė AB informs that on 16 April 2024 a letter from the company’s shareholder UAB EDS INVEST 3 was received regarding the intention to submit a mandatory non-competitive takeover bid for the acquisition of the remaining shares of  Snaigė AB. The addition: Notice on the intention to submit a non-competitive mandatory takeover bid by UAB EDS INVEST 3.          General Director  Darius Varnas  Phone No. +370 315 56200AttachmentEDS_INVEST_3 Pranešimas apie ketinimą teikti oficialų siūlymą_2024-04-16_Snaigė

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.